rs104894810
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000166.6(GJB1):c.424C>T(p.Arg142Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000915 in 1,092,375 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R142Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000166.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJB1 | NM_000166.6 | c.424C>T | p.Arg142Trp | missense_variant | Exon 2 of 2 | ENST00000361726.7 | NP_000157.1 | |
GJB1 | NM_001097642.3 | c.424C>T | p.Arg142Trp | missense_variant | Exon 2 of 2 | NP_001091111.1 | ||
GJB1 | XM_011530907.3 | c.424C>T | p.Arg142Trp | missense_variant | Exon 2 of 2 | XP_011529209.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD2 exomes AF: 0.00000588 AC: 1AN: 170000 AF XY: 0.0000178 show subpopulations
GnomAD4 exome AF: 9.15e-7 AC: 1AN: 1092375Hom.: 0 Cov.: 31 AF XY: 0.00000279 AC XY: 1AN XY: 358273 show subpopulations
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:4
The c.424C>T, variant found is located in exon 2. Most predictors characterize the variant as Deleterious (PP3), the patient's phenotype and family history are highly specific for this Mendelian disease: Asymmetric bilateral pes cavus, gait disturbances, suspected hereditary neuropathy (PP4), the variant is located in a well-established functional domain: it is in a Connexin domain, right in the transmembrane passage region (PM1), a rare variant is observed in unrelated individuals with the same phenotype and is absent in control individuals, there are 4 reports in ClinVar of patients with this syndrome and this same variant (VCV000010431.15) (PS4), the variant was not found in the general population (PM2_Supporting), it is a missense variant in a gene with a low benign missense rate (Z score 3.96) (PP2), there are functional studies that show that this variant causes the pathology (PMID:19369543)(PS3) -
- -
- -
- -
not provided Pathogenic:2
GJB1: PS4, PM2, PM5, PS3:Moderate, PP3 -
Published functional studies demonstrate a damaging effect, with the R142W variant forming no functional intercellular channels and demonstrating impaired connexon assembly (Bruzzone et al., 1994; VanSlyke et al., 2000); Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 8004109, 22771394, 10207904, 10848620, 9364054, 8266101, 7946361, 28286897) -
Charcot-Marie-Tooth Neuropathy X Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 142 of the GJB1 protein (p.Arg142Trp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with Charcot-Marie-Tooth disease, type IX (PMID: 8004109, 8266101, 10873293, 25947624). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 10431). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GJB1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects GJB1 function (PMID: 7946361, 9364054, 10848620). This variant disrupts the p.Arg142 amino acid residue in GJB1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11571214). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at